Client needed help to support development of local medical launch readiness plans including local medical objectives, competitive positioning, scientific narrative, and data generation, and stakeholder engagement strategy for a new vaccine.
We developed a framework to systematically assess medical planning for the asset that included the medical objectives, competitive positioning, scientific narrative, data generation, and stakeholder engagement. Country-specific syntheses of strategic considerations were developed to inform medical planning. The significance and feasibility of supporting the asset scientific narratives were considered by country.
We provided an executive summary of the asset’s medical objectives, key scientific narratives, gaps and potential challenges, country action plans, and implications for regional and global.
Jump to a slide with the slide dots.
A biopharma client with an early clinical stage compound, showing efficacy across multiple neuropsychiatric conditions, wished to prioritize...
Read moreA large biopharma client objective aimed to optimize its omnichannel (OC) approach for HCP and patient Medical Education...
Read moreA top biopharma client wanted to understand diagnosis and treatment patterns for a rare respiratory disease only recently associated as a sequela....
Read more